This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignees: Cilian Ag, Sanofi Pasteur Sa. Active years: 2012-2013.
Location History:
- Münster, DE (2012)
- Muenster, DE (2013)
Company Filing History:
Years Active: 2012-2013
Title: Ulrike Bockau: Innovator in Viral Protein Expression
Introduction
Ulrike Bockau is a prominent inventor based in Muenster, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of viral protein expression. With a total of 2 patents, her work has implications for various applications in research and medicine.
Latest Patents
Ulrike Bockau's latest patents include a system for the heterologous expression of a viral protein in a ciliate host cell. This invention relates to a system that comprises nucleic acid and its use in effecting ciliate Tetrahymena bifunctional dihydrofolate reductase-thymidylate synthase deficiency. Additionally, she has developed a method for producing a ciliate cell with reduced or essentially no dihydrofolate reductase (DHFR) activity or reduced or essentially no thymidylate synthase (TS) activity, or both.
Career Highlights
Throughout her career, Ulrike has worked with notable companies such as Cilian Ag and Sanofi Pasteur SA. Her expertise in biotechnology has allowed her to contribute to innovative projects that advance the understanding of viral proteins and their applications.
Collaborations
Ulrike has collaborated with esteemed colleagues, including Marcus Hartmann and Thomas Weide. These partnerships have fostered a collaborative environment that enhances research and development in her field.
Conclusion
Ulrike Bockau's contributions to the field of biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in viral protein expression and related applications.